Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-05-16Clinical Trial Update: Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia [Phase 3]
Phase 3 clinical trial update evaluating dopamine transporter imaging with ioflupane (DaTscan) in Lewy body dementia and other dementias has …
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease [NA]
This completed clinical trial evaluated a caregiver intervention combined with donepezil (Aricept) for individuals with mild to moderate Alz…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease [Phase 2]
A Phase 2 trial tested daily GTS-21 (ispronicline) for 28 days in participants with probable Alzheimer's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-03-16Clinical Trial Update: Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects [Phase 1]
Completed Phase 1 study evaluating the safety of Lecozotan SR in healthy young and elderly subjects; sponsored by Wyeth, now a Pfizer subsid…
-
CLINICAL_TRIALS research · 2007-03-16Clinical Trial Update: Evaluating the Effects of Music Interventions on Hospitalised People With Dementia [Phase 2, Phase 3]
The document describes an ongoing Phase 2/Phase 3 clinical trial evaluating music interventions for hospitalized people with dementia, inclu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-02-28Clinical Trial Update: Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating 3APS in patients with mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2007-02-06Clinical Trial Update: Effect of Indomethacin on the Progression of Alzheimer's Disease [Phase 3]
This update covers a completed Phase 3 trial evaluating whether indomethacin can modify the progression of Alzheimer's disease.
-
FDA approval · 2006-12-21FDA Approved: FLUDEOXYGLUCOSE F18 — Supplemental Application (THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH)
FDA approved a supplemental application for Fludeoxyglucose F18, a PET imaging radiopharmaceutical, expanding its regulatory status.
-
CLINICAL_TRIALS trial_result · 2006-11-14Clinical Trial Update: PACT: Providers and Alzheimer's Caregivers Together [NA]
The National Institute on Aging reports the completion of the PACT trial (Providers and Alzheimer's Caregivers Together), a study investigat…
-
CLINICAL_TRIALS trial_result · 2006-11-09Clinical Trial Update: Lipitor as a Treatment for Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating Lipitor (atorvastatin) for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-10-24Clinical Trial Update: Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Panax ginseng for cognitive performance in Alzheimer's disease has completed. The snippet does not inclu…
-
FDA approval · 2006-10-13FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc., updating the product labeling in conn…
-
FDA approval · 2006-10-04FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for memantine hydrochloride by Actavis Pharma, Inc., resulting in an approved update to the product'…
-
CLINICAL_TRIALS trial_result · 2006-09-19Clinical Trial Update: Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease [Phase 1, Phase 2]
This document reports a completed Phase 1/2 safety trial of PPI-1019 in adults with mild-to-moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2006-09-19Clinical Trial Update: Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease [Phase 1]
A Phase 1 safety study evaluating PPI-1019 in patients with mild-to-moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-12Clinical Trial Update: COGNIShunt® System for Alzheimer's Disease [Phase 3]
A Phase 3 trial of the COGNIShunt System for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Positron Emission Tomography of Amyloid in Alzheimer's Disease [Phase 1]
Phase 1 clinical trial investigating PET imaging of amyloid in Alzheimer's disease. The study status is suspended.
-
CLINICAL_TRIALS trial_result · 2006-09-04Clinical Trial Update: A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating multiple doses of ABT-089 in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia [Phase 4]
Phase 4 trial comparing escitalopram to placebo for depressive symptoms in patients with Alzheimer's disease, vascular dementia, or mixed de…
-
CLINICAL_TRIALS trial_result · 2006-07-27Clinical Trial Update: Care Management for Patients With Alzheimer Disease and Their Family Caregivers [NA]
A clinical trial update describing care management for patients with Alzheimer's disease and their family caregivers; sponsor is the Agency …
-
CLINICAL_TRIALS trial_result · 2006-07-26Clinical Trial Update: High Intensity Light Therapy in Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating high intensity light therapy for Alzheimer's disease has completed. The study includes participants with Alzheime…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Phase 2]
Phase 2 study evaluating the efficacy and safety of LY451395 in patients with probable Alzheimer's disease.
-
FDA approval ·FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
FDA approves Auvelity as the first non-antipsychotic drug to treat agitation associated with dementia due to Alzheimer’s disease in adults.